Vaccine no replacement for Pap test

	Tweet

Responding to news that the Therapeutic Goods Administration (TGA) has approved Australia’s first cervical cancer vaccine, The Cancer Council Australia cautioned that the vaccine was not a substitute for the Pap screen and that all women aged 18-69 should continue regular two year screening.

The Cancer Council Australia’s CEO, Ian Olver, said: “While the vaccine is an exciting prospect for future generations, in Australia the Pap test is currently the best protection against cervical cancer for women who have ever had sex.

“Even for girls who are vaccinated, Pap tests will still be important. This is because the vaccine is effective against two specific strains of human papilloma virus (HPV), and whilst these strains cause up to 70 per cent of cervical cancers, the vaccine does not protect against all types of cancer-causing HPV.”

Pioneered by Australian of the Year Ian Frazer, the first cervical cancer vaccine- Gardasil, manufactured by CSL Limited- has now been approved by the TGA and will be available in Australia later this year. A second vaccine, produced by GSK Limited, is also expected on the market later this year.

Recommended for girls before they become sexually active, the vaccine protects against specific strains of HPV that cause around 70 per cent of cervical cancers.

Kate Broun, manager of PapScreen Victoria, also moved to reassure parents who may be concerned about the cost of the vaccine, which is estimated to be several hundred dollars.

“Given the vaccine is not currently listed on the Pharmaceutical Benefits Scheme, parents will need to pay for the full cost of the vaccine out of their own pockets. Parents can be reassured, however, that Pap tests are still an effective preventative measure against cervical cancer.

“Australia has the lowest cervical cancer mortality in the world. This reflects the success of our national cervical screening program. Our message to parents is that there are now two preventative measures for cervical cancer, which complement each other,” she added.

The benefits of Pap tests

• Regular two-yearly Pap tests reduce the incidence of cervical cancer by up to 90%.
  
• The Pap test can detect cervical abnormalities caused by genital HPV.
  
• Regular Pap tests allow any changes to the cells of the cervix to be identified and managed well before they may become cancerous.

Key information for women about HPV

• Four out of five women will have HPV at some time in their life.
  
• Many women have HPV and never know it, as the body’s immune system usually clears the virus in around one to two years.
  
• HPV often has no symptoms, but can sometimes cause genital warts or cervical cell changes.
  
• Genital HPV is spread by genital skin contact during sexual activity - condoms offer limited protection as they do not cover all of the genital skin.
  
• Most women with genital HPV will not develop cervical cancer.

http://www.cancer.org.au

RELATED STORIES:
New MRI technique may identify cervical cancer early   Post-treatment PET Scans Can Reassure Cervical Cancer Patients   Couples more likely to divorce if spouse develops cervical or testicular cancer   Stress May Increase a Woman’s Risk of Developing Cervical Cancer   Cervical cancer survivors prone to other cancers   Merck’s cervical cancer vaccine on sale in Europe   Virus causes rare form of cervical cancer too   Singapore questions cervical cancer vaccine for teens   Screening for cervical cancer low for immigrant women   Merck cervical cancer shot gives 5-year protection   Optimal Treatment and Minimal Complications in Cervical Cancer Patients   Coils almost halve risk of cervical cancer: study   How Medical Center Research Led to New Cervical Cancer Vaccine   Obese women in Canada are less likely to be screened for cervical cancer   CDC recommends human papillomavirus virus vaccination   Protein found to be the link missing between HPV infection and cervical cancer development   The Pill doesn’t affect cervical pre-cancer risk   Study indicates vaccine prevents cervical cancer   Merck says US CDC endorses cervical cancer vaccine   Annual cervical cancer screening persists, despite recommended guidelines   Study determines costs of breast and cervical cancer detection among low-income women   Cervical disease sufferers could benefit from HPV vaccine

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]